Salim Shah, PhD, JD
Sarfez Pharmaceuticals, Inc.
4
0
3
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (4)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Dusan Kocovic, MD
Main Line Health Center/Lankenau Hospital, Wynnewood, PA
Shared therapeutic areas:
Lawrence Czer, MD
Cedars-Sinai Medical Center, Los Angeles, CA
Shared therapeutic areas:
Joseph Rogers, MD
Duke University Medical Center, Durham, NC
Shared therapeutic areas:
Daniel Landa, MD
St. Jude Hospital, Fullerton, CA
Shared therapeutic areas:
Hamid Gourabi, PhD
head of Royan Institute
Shared therapeutic areas:
Zi-Juan Xu, MD
Sutter Memorial Hospital, Sacramento, CA
Shared therapeutic areas:
John P. McKenzie III, MD
Glendale Memorial Hospital and Medical Center, Glendale, CA
Shared therapeutic areas:
Hamang Patel, MD
Ochsner Health System
Shared therapeutic areas:
Peter Fattal, MD
MidMichigan Physicians Group, Midland, MI
Shared therapeutic areas:
Suman Wason, MD
Lexicon Pharmaceuticals, Inc.
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (4)
Showing 4 of 4 trials
Bioavailability and Bioequivalence Study of ER Torsemide and Spironolactone FDC Tablet in Healthy Subjects
A Study to Evaluate the Effect of Food or no Food on the Bioavailability of an Extended Release (ER) Torsemide and Spironolactone Fixed Dose Combination (FDC) Tablet in Healthy Adult Subjects
Bioavailability and Bioequivalence Study of Extended Release Torsemide and Spironolactone
Comparing Natriuretic Effects of ER Torsemide to IR Torsemide in Patients With Heart Failure
All 4 trials loaded